DekaBank Deutsche Girozentrale’s Myriad Genetics MYGN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154K	Hold	35,272	–	–	﹤0.01%	994
2026 Q1	$158K	Hold	35,272	–	–	﹤0.01%	995
2025 Q4	$757K	Hold	35,272	–	–	﹤0.01%	931
2025 Q3	$252K	Hold	35,272	–	–	﹤0.01%	1095
2025 Q2	$183K	Hold	35,272	–	–	﹤0.01%	1145
2025 Q1	$309K	Hold	35,272	–	–	﹤0.01%	1047
2024 Q4	$465K	Hold	35,272	–	–	﹤0.01%	1017
2024 Q3	$929K	Hold	35,272	–	–	﹤0.01%	899
2024 Q2	$855K	Hold	35,272	–	–	﹤0.01%	911
2024 Q1	$751K	Buy	35,272 +2,980	+9%	+$64.1K	﹤0.01%	926
2023 Q4	$631K	Hold	32,292	–	–	﹤0.01%	992
2023 Q3	$540K	Buy	32,292 +4,192	+15%	+$79.8K	﹤0.01%	997
2023 Q2	$644K	Hold	28,100	–	–	﹤0.01%	979
2023 Q1	$629K	Hold	28,100	–	–	﹤0.01%	970
2022 Q4	$408K	Hold	28,100	–	–	﹤0.01%	1080
2022 Q3	$544K	Hold	28,100	–	–	﹤0.01%	1026
2022 Q2	$513K	Hold	28,100	–	–	﹤0.01%	1016
2022 Q1	$717K	Buy	28,100 +2,600	+10%	+$66.5K	﹤0.01%	981
2021 Q4	$701K	Buy	25,500 +700	+3%	+$20.3K	﹤0.01%	1025
2021 Q3	$801K	Hold	24,800	–	–	﹤0.01%	951
2021 Q2	$750K	Hold	24,800	–	–	﹤0.01%	979
2021 Q1	$721K	Hold	24,800	–	–	﹤0.01%	964
2020 Q4	$449K	Sell	24,800 -1,200	-5%	-$19.4K	﹤0.01%	1043
2020 Q3	$324K	Buy	+26,000	New	+$329K	﹤0.01%	988
2019 Q4	–	Sell	-26,800	Closed	-$763K	–	1185
2019 Q3	$763K	Sell	26,800 -10,800	-29%	-$315K	﹤0.01%	716
2019 Q2	$1.01M	Buy	37,600 +14,700	+64%	+$415K	0.01%	787
2019 Q1	$1.14M	Buy	22,900 +4,100	+22%	+$125K	0.01%	732
2018 Q4	$535K	Sell	18,800 -4,100	-18%	-$147K	﹤0.01%	817
2018 Q3	$1.14M	Sell	22,900 -600	-3%	-$26.7K	0.01%	746
2018 Q2	$873K	Sell	23,500 -15,651	-40%	-$529K	0.01%	779
2018 Q1	$1.16M	Sell	39,151 -6,642	-15%	-$225K	0.01%	686
2017 Q4	$1.27M	Hold	45,793	–	–	0.01%	637
2017 Q3	$1.27M	Hold	45,793	–	–	0.01%	645
2017 Q2	$1.18M	Buy	45,793 +21,793	+91%	+$463K	0.01%	652
2017 Q1	$459K	Sell	24,000 -2,000	-8%	-$35.4K	﹤0.01%	749
2016 Q4	$434K	Buy	26,000 +2,000	+8%	+$36.2K	﹤0.01%	685
2016 Q3	$497K	Buy	24,000 +2,674	+13%	+$67.8K	0.01%	666
2016 Q2	$652K	Sell	21,326 -76,174	-78%	-$2.65M	0.01%	628
2016 Q1	$3.63M	Buy	97,500 +29,000	+42%	+$1.09M	0.04%	359
2015 Q4	$3.01M	Buy	68,500 +33,600	+96%	+$1.42M	0.03%	408
2015 Q3	$1.31M	Buy	34,900 +300	+0.9%	+$10.6K	0.02%	513
2015 Q2	$1.18M	Buy	34,600 +1,300	+4%	+$44.2K	0.01%	538
2015 Q1	$1.18M	Sell	33,300 -5,700	-15%	-$204K	0.01%	546
2014 Q4	$1.36M	Sell	39,000 -3,600	-8%	-$128K	0.02%	520
2014 Q3	$1.64M	Sell	42,600 -300	-0.7%	-$11.2K	0.02%	446
2014 Q2	$1.67M	Sell	42,900 -7,600	-15%	-$283K	0.03%	440
2014 Q1	$1.73M	Buy	50,500 +4,700	+10%	+$146K	0.03%	395
2013 Q4	$952K	Buy	45,800 +1,300	+3%	+$32.9K	0.02%	443
2013 Q3	$1.05M	Buy	+44,500	New	+$1.26M	0.02%	420

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MYGN Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Myriad Genetics (MYGN) position steady in Q2 2026 at 35,272 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #994.

DekaBank Deutsche Girozentrale first reported a position in MYGN in Q3 2013 and has held it in 49 quarters since. The position peaked at $3.63M in Q1 2016. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

DekaBank Deutsche Girozentrale held 35,272 shares of Myriad Genetics worth $154K as of Q2 2026.
DekaBank Deutsche Girozentrale left its Myriad Genetics share count unchanged in Q2 2026.
Myriad Genetics made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #994 holding.
DekaBank Deutsche Girozentrale first reported a position in Myriad Genetics in Q3 2013 and has held it in 49 quarters since.
DekaBank Deutsche Girozentrale's Myriad Genetics position peaked at $3.63M in Q1 2016.
196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.